Adverum Biotechnologies

Yahoo Finance • 7 days ago

Shinobi Therapeutics Announces the Appointment of Dr. Laurent Fischer as Chair of its Board of Directors

Dr Fischer brings 30+ years of experience leading and exiting innovative biotech companies focused on developing and commercializing breakthrough therapies, including Adverum Biotechnologies, recently acquired by Eli Lilly Shinobi prepares... Full story

Yahoo Finance • 21 days ago

Halper Sadeh LLC Encourages ADVM, MOFG, HSII Shareholders to Contact the Firm to Discuss Their Rights

NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 21 days ago

Adverum Biotechnologies Buyout by Eli Lilly Represents 'Best Possible Outcome' for Company, Mizuho Says

Adverum Biotechnologies' (ADVM) deal to be acquired by Eli Lilly (LLY) represents a likely "best pos PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 21 days ago

Eli Lilly to Acquire Eye Gene Therapy Developer Adverum Biotechnologies

Eli Lilly (LLY) has agreed to acquire Adverum Biotechnologies (ADVM), which is developing a therapy PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 21 days ago

Eli Lilly to buy Adverum, General Dynamics stock hits new record

Market Catalysts host Julie Hyman tracks several of the day's top trending stock tickers, including Eli Lilly's (LLY) deal to acquire Adverum Biotechnologies (ADVM), gold miner Newmont's (NEM) cost-cutting initiatives, and General Dynamics... Full story

Yahoo Finance • 21 days ago

ADVM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Adverum Biotechnologies, Inc. is Fair to Shareholders

NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Adverum Biotechnologies, Inc. (NASDAQ: ADVM) to Eli Lilly and Company is fair to Adverum shareholders. Under... Full story

Yahoo Finance • 21 days ago

Eli Lilly to Acquire Adverum Biotechnologies for Up to $12.47 a Share

Eli Lilly (LLY) has agreed to acquire Adverum Biotechnologies (ADVM) including its lead product cand PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 2 months ago

Presenting on Emerging Growth Conference 86 Day 2 September 25; Register to live stream

MIAMI, Sept. 24, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 86th Emerging Growth Conference on September 24 & 25, 2025. The Emerging Growth Conference identifie... Full story

Yahoo Finance • 2 months ago

Presenting on Emerging Growth Conference 86 Day 1 on September 24; Register to live stream

MIAMI, Sept. 23, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 86th Emerging Growth Conference on September 24 & 25, 2025. The Emerging Growth Conference identifie... Full story

Yahoo Finance • 2 months ago

Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum’s Board of Directors granted inducement awards consisting of non-qualified s... Full story

Yahoo Finance • 3 months ago

Presenting on Emerging Growth Conference 85 Day 2 on August 21; Register to live stream

MIAMI, Aug. 20, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 85th Emerging Growth Conference on August 20 & 21, 2025. The Emerging Growth Conference identifies co... Full story

Yahoo Finance • 3 months ago

Presenting on Emerging Growth Conference 85 Day 1 on August 20; Register to live stream

MIAMI, Aug. 19, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 85th Emerging Growth Conference on August 20 & 21, 2025. The Emerging Growth Conference identifies co... Full story

Yahoo Finance • 3 months ago

Hospital Information Systems Company Evaluation Report 2025 | Epic Systems, AdvancedMD, and Dedalus Lead with Integrated EHR, Practice Management, and Digital Transformation Solutions

Dublin, Aug. 13, 2025 (GLOBE NEWSWIRE) -- The "Hospital Information Systems Company Evaluation" report has been added to ResearchAndMarkets.com's offering. The Hospital Information System Companies Quadrant is a comprehensive industr... Full story

Yahoo Finance • 3 months ago

Adverum Biotechnologies to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference

REDWOOD CITY, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that Laurent Fischer, MD, President and Chief Executive Officer, and Szilárd Kiss, MD, Distinguished Professor of Ophtha... Full story

Yahoo Finance • 4 months ago

Presenting on Emerging Growth Conference 84 Day 2 on July 17; Register to live stream

MIAMI, July 16, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 84th Emerging Growth Conference on July 16 & 17, 2025. The Emerging Growth Conference identifies comp... Full story

Yahoo Finance • 4 months ago

Presenting on Emerging Growth Conference 84 Day 1 on July 16; Register to live stream

MIAMI, July 15, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 84th Emerging Growth Conference on July 16 & 17, 2025. The Emerging Growth Conference identifies comp... Full story

Yahoo Finance • 5 months ago

Adverum Biotechnologies price target lowered to $12 at Mizuho

Investing.com - Mizuho lowered its price target on Adverum Biotechnologies (NASDAQ:ADVM) stock to $12.00 from $16.00 on Wednesday, while maintaining an Outperform rating on the shares. The stock, currently trading at $2.58, sits well below... Full story

Yahoo Finance • 5 months ago

Adverum Biotechnologies' SWOT analysis: gene therapy stock faces pivotal year

Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a biotechnology company focused on developing gene therapies for ocular and rare diseases, stands at a critical juncture in its journey to bring innovative treatments to market. With a market ca... Full story

Yahoo Finance • 6 months ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM

NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Adverum Biotechnologies, Inc. (“Adverum” or the “Company”) (NASDAQ: ADVM).  Such investors are advised to contact Danielle Peyton... Full story

Yahoo Finance • 7 months ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Adverum Biotechnologies, Inc. (“Adverum” or the “Company”) (NASDAQ: ADVM).  Such investors are advised to contact Danielle Peyt... Full story